Cargando…
Pharmaceutical economics and policy /
The pharmaceutical industry is praised as a world leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. At the same time, the industry is also criticized for its marketing and pricing practices and for its a...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Oxford ; New York :
Oxford University Press,
2007.
|
| Edición: | 2nd ed. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn710992761 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 110404s2007 enka ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCLCE |d E7B |d OCLCQ |d YDXCP |d EBLCP |d OCLCQ |d OCLCF |d OCLCQ |d NLGGC |d OCLCO |d OCLCQ |d AZK |d AGLDB |d OCLCQ |d MOR |d OCLCO |d LIP |d PIFAG |d ZCU |d OCLCO |d MERUC |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d U3W |d OCLCA |d KIJ |d STF |d WRM |d OCLCQ |d NRAMU |d OCLCA |d ICG |d OCLCO |d VT2 |d AU@ |d OCLCQ |d WYU |d OCLCA |d DKC |d OCLCO |d OCLCQ |d UX1 |d OCLCQ |d OCLCA |d UKCRE |d BOL |d INARC |d OCLCA |d UKAHL |d OCLCQ |d OCLCO |d OCLCQ |d YDX |d OCLCO |d OCLCL | ||
| 015 | |a GBA671631 |2 bnb | ||
| 016 | 7 | |a 101266298 |2 DNLM | |
| 016 | 7 | |a 013536538 |2 Uk | |
| 019 | |a 655158139 |a 764556838 |a 961507590 |a 962574829 |a 988487185 |a 990480256 |a 992111859 |a 1037719374 |a 1038614021 |a 1045446806 |a 1055330858 |a 1058438568 |a 1064153338 |a 1081285735 |a 1114478375 |a 1153540473 |a 1194917605 |a 1228535532 | ||
| 020 | |a 9780199719747 |q (electronic bk.) | ||
| 020 | |a 0199719748 |q (electronic bk.) | ||
| 020 | |z 0195300955 | ||
| 020 | |z 9780195300956 | ||
| 029 | 1 | |a AU@ |b 000053269079 | |
| 029 | 1 | |a DEBBG |b BV042965407 | |
| 029 | 1 | |a DEBBG |b BV044163829 | |
| 029 | 1 | |a DEBSZ |b 423791206 | |
| 029 | 1 | |a NZ1 |b 13871252 | |
| 029 | 1 | |a AU@ |b 000068972310 | |
| 035 | |a (OCoLC)710992761 |z (OCoLC)655158139 |z (OCoLC)764556838 |z (OCoLC)961507590 |z (OCoLC)962574829 |z (OCoLC)988487185 |z (OCoLC)990480256 |z (OCoLC)992111859 |z (OCoLC)1037719374 |z (OCoLC)1038614021 |z (OCoLC)1045446806 |z (OCoLC)1055330858 |z (OCoLC)1058438568 |z (OCoLC)1064153338 |z (OCoLC)1081285735 |z (OCoLC)1114478375 |z (OCoLC)1153540473 |z (OCoLC)1194917605 |z (OCoLC)1228535532 | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a HD9666.5 |b .S385 2007eb | |
| 060 | 4 | |a QV 736 |b S413p 2007 | |
| 072 | 7 | |a BUS |x 070130 |2 bisacsh | |
| 082 | 0 | 4 | |a 338.4/761510973 |2 22 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Schweitzer, Stuart O. | |
| 245 | 1 | 0 | |a Pharmaceutical economics and policy / |c Stuart O. Schweitzer. |
| 250 | |a 2nd ed. | ||
| 260 | |a Oxford ; |a New York : |b Oxford University Press, |c 2007. | ||
| 300 | |a 1 online resource (xiv, 336 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 340 | |g polychrome. |2 rdacc |0 http://rdaregistry.info/termList/RDAColourContent/1003 | ||
| 347 | |a text file |2 rdaft |0 http://rdaregistry.info/termList/fileType/1002 | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a The pharmaceutical industry -- The biotechnology industry -- Other firms in the pharmaceutical industry -- Marketing pharmaceuticals -- The demand for pharmaceuticals -- Pharmaceutical prices -- The worldwide market for pharmaceuticals -- Pricing pharmaceuticals in a world environment -- The timing of drug approvals in the United States and abroad -- Pharmaceutical regulation and cost containment by the public sector -- Regulation by the private sector -- Pharmaceutical regulation in Europe -- Patent protection -- Evaluating New Drugs -- Complementary and alternative medicines -- Pharmaceuticals and health policy : a look ahead. | |
| 520 | |a The pharmaceutical industry is praised as a world leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. At the same time, the industry is also criticized for its marketing and pricing practices and for its apparent anticompetitive responses to generic competition. Even its research and development priorities are criticized as being too closely driven by the goal of maximizing shareholder value, rather than the health of the public. Unfortunately, many of the critics of the industry fail to understand the complexities of the industry and its role in the nation's healthcare system. This book uses the tools of economic analysis to explore the conflicting priorities and aims of the pharmaceutical industry, from both an American and worldwide perspective. This is the second edition of a uniquely comprehensive and balanced discussion of pharmaceutical policy issues. All the chapters of the former edition have been fully re-written and extensively updated. In addition, the book includes six new chapters on emerging topics such as the broadened role of FDA regulations and the increasing diversity of the industry. An entire chapter is devoted to the biotechnology industry and one to alternative medicines, often called "nutraceuticals." Another new chapter discusses segments of the industry that specialize in particular activities including generic drugs and drug delivery systems. The recent controversial expansion of Medicare to cover outpatient drugs is discussed in depth. The introduction is also updated to address the volatile pace of pharmaceutical innovation and how the pharmaceutical industry has responded to the emergence of managed care | ||
| 588 | 0 | |a Print version record. | |
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Pharmaceutical industry |z United States. | |
| 650 | 0 | |a Pharmaceutical policy |z United States. | |
| 650 | 0 | |a Pharmaceutical industry. | |
| 650 | 1 | 2 | |a Economics, Pharmaceutical |
| 650 | 2 | 2 | |a Drug Industry |
| 650 | 2 | 2 | |a Public Policy |
| 651 | 2 | |a United States | |
| 650 | 6 | |a Industrie pharmaceutique |z États-Unis. | |
| 650 | 6 | |a Médicaments |x Politique gouvernementale |z États-Unis. | |
| 650 | 6 | |a Industrie pharmaceutique. | |
| 650 | 6 | |a Pharmacoéconomie. | |
| 650 | 7 | |a BUSINESS & ECONOMICS |x Industries |x Pharmaceutical & Biotechnology. |2 bisacsh | |
| 650 | 7 | |a Pharmaceutical industry |2 fast | |
| 650 | 7 | |a Pharmaceutical policy |2 fast | |
| 651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 776 | 0 | 8 | |i Print version: |a Schweitzer, Stuart O. |t Pharmaceutical economics and policy. |b 2nd ed. |d Oxford ; New York : Oxford University Press, 2007 |z 0195300955 |w (DLC) 2006003075 |w (OCoLC)63277820 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=886688 |z Texto completo |
| 938 | |a YBP Library Services |b YANK |n 20447682 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH28533167 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH24087193 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL886688 | ||
| 938 | |a ebrary |b EBRY |n ebr10460685 | ||
| 938 | |a EBSCOhost |b EBSC |n 191561 | ||
| 938 | |a Internet Archive |b INAR |n pharmaceuticalec0000schw_n2g7 | ||
| 938 | |a YBP Library Services |b YANK |n 3875136 | ||
| 994 | |a 92 |b IZTAP | ||